Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D3 ameliorates R-loop-induced replication stress and chromosomal instability in MED12-mutant uterine fibroids

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

For in vitro analyses, primary cells were isolated at UT Health San Antonio from MM and UF samples collected as fresh tissues from patients providing informed consent and undergoing hysterectomy for symptomatic UFs.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D3 ameliorates R-loop-induced replication stress and chromosomal instability in MED12-mutant uterine fibroids

Study design awaiting verification · Research Square · 2026

Original publication title

Vitamin D3 ameliorates R-loop-induced replication stress and chromosomal instability in MED12-mutant uterine fibroids

Sribalasubashini Muralimanoharan; Ana Corachán; Azad Khosh; Sierra Hathaway; Susivarshini Karthigayan; Claire Schenken; Nicholas Stansbury; Robert Schenken; Maria Victoria Bariani; Qiwei Yang; Eloise Dray; Mazhar Adli; Hortensia Ferrero; Ayman Al-Hendy; Thomas G. Boyer

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Uterine fibroids (UFs) are the most important benign neoplastic threat to women’s health worldwide, with no long-term noninvasive treatment options currently available. Among known UF driver alterations, somatic mutations in Mediator subunit MED12 are by the far the most prevalent, accounting for up to 80% of these clinically significant lesions. Although it is presently unclear how MED12 mutations trigger neoplastic transformation, MED12-mutant UFs are nonetheless characterized by significant chromosomal loss and rearrangement, suggesting genomic instability as a driving force in tumor development.

However, the basis by which MED12 mutations drive genomic instability is not known. Herein, we show that R-loop-driven replication stress in MED12-mutant UFs leads to DNA under-replication and mitotic segregation errors that drive chromosomal instability. Notably, we find that vitamin D3 (VD3), a modifiable risk factor in UF development, suppresses pathogenic R-loop accrual and ameliorates replication stress-driven chromosomal instability, contributing to growth inhibition of patient-derived MED12-mutant UF xenografts in vivo. Altogether these findings uncover a molecular basis by which the predominant UF driver converges with a known risk factor at the interface of genomic instability, with significant translational implications for personalized UF prevention and treatment.

Authors’ abstract

Uterine fibroids (UFs) are the most important benign neoplastic threat to women’s health worldwide, with no long-term noninvasive treatment options currently available. Among known UF driver alterations, somatic mutations in Mediator subunit MED12 are by the far the most prevalent, accounting for up to 80% of these clinically significant lesions. Although it is presently unclear how MED12 mutations trigger neoplastic transformation, MED12-mutant UFs are nonetheless characterized by significant chromosomal loss and rearrangement, suggesting genomic instability as a driving force in tumor development.

However, the basis by which MED12 mutations drive genomic instability is not known. Herein, we show that R-loop-driven replication stress in MED12-mutant UFs leads to DNA under-replication and mitotic segregation errors that drive chromosomal instability. Notably, we find that vitamin D3 (VD3), a modifiable risk factor in UF development, suppresses pathogenic R-loop accrual and ameliorates replication stress-driven chromosomal instability, contributing to growth inhibition of patient-derived MED12-mutant UF xenografts in vivo. Altogether these findings uncover a molecular basis by which the predominant UF driver converges with a known risk factor at the interface of genomic instability, with significant translational implications for personalized UF prevention and treatment.

Publication and source details

Original title: Vitamin D3 ameliorates R-loop-induced replication stress and chromosomal instability in MED12-mutant uterine fibroids

Sribalasubashini Muralimanoharan; Ana Corachán; Azad Khosh; Sierra Hathaway; Susivarshini Karthigayan; Claire Schenken; Nicholas Stansbury; Robert Schenken; Maria Victoria Bariani; Qiwei Yang; Eloise Dray; Mazhar Adli; Hortensia Ferrero; Ayman Al-Hendy; Thomas G. Boyer

Research Square · 2026

*

Equal contribution

Author Contributions

S.M., A.C., Q.Y., E.D., H.F., A.A-H., and T.G.B. conceived the study, designed experiments, and analyzed data. S.M., A.C., S.H., M.V.B., and S.K. performed experiments. S.M., A.C., E.D., H.F., A.A-H., A.K., and T.G.B analyzed the results. A.K. performed bioinformatics analysis. C.S., N.S. and R.S. obtained patient consent and performed surgeries. M.A. provided key reagents and expert insight. S.M. and T.G.B. wrote the manuscript. S.M. and A.C. were largely responsible for in vitro and in vivo studies, respectively, both of which were equally important to achieve the conclusions of the study.

Based on committed effort, S.M. is listed first among the two primary co-authors. Research funding for the studies herein was acquired by A.-A-H. and T.G.B. All authors read and approved the manuscript.

# Correspondence: Thomas G. Boyer, Department of Molecular Medicine, UT Health San Antonio, Department of Molecular Medicine, 8210 Floyd Curl Drive, Mail Code 8257, STRF, San Antonio, Texas 78229-3900, NET: boyer@uthscsa.edu
https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of HealthR01ES028615R01HD087417R01HD106285University of Chicago Genomics FacilitySCR 019196

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:21:58.891729+00:00

DOI: 10.21203/rs.3.rs-8031602/v1 · PMC12869685